MEDSIR

MEDSIR, founded in 2012, collaborates closely with partners to drive innovation in oncology research. Headquartered in Spain and the United States, the company manages all aspects of clinical research, from study design to publication, leveraging a global network of experts and integrated technology to streamline processes. MEDSIR provides proof-of-concept support and strategic approaches, enabling research partners to benefit from the best of both worlds: industry-sponsored clinical trials and investigator-initiated studies. To promote independent global cancer research, MEDSIR has established a strategic alliance with Oncoclínicas, Brazil's leading oncology group with the largest research potential in South America.